Legend Biotech Corporation (LEGN) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Legend Biotech Corporatio...

    NASDAQ: LEGN · Real-Time Price · USD
    32.82
    -0.06 (-0.18%)
    At close: Sep 25, 2025, 3:59 PM
    32.81
    -0.03%
    After-hours: Sep 25, 2025, 07:53 PM EDT

    Legend Biotech Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 627.24M 285.14M 117M 89.79M
    Cost of Revenue
    		 234.58M 144.21M 65.36M 313.35M
    Gross Profit
    		 392.66M 140.93M 51.64M -223.55M
    Operating Income
    		 -303.24M -439.49M -455.83M -393.02M
    Interest Income
    		 61.2M 54.49M 8.18M 971K
    Pretax Income
    		 -158.13M -520.12M -445.72M -386.21M
    Net Income
    		 -177.03M -518.25M -446.35M -386.21M
    Selling & General & Admin
    		 284.26M 200.93M 174.05M 149.48M
    Research & Development
    		 413.54M 382.22M 335.65M 313.35M
    Other Expenses
    		 -1.91M n/a 2.23M -6.07M
    Operating Expenses
    		 695.9M 140.93M 509.7M 462.83M
    Interest Expense
    		 21.61M 21.79M 10.8M 900K
    Selling & Marketing Expenses
    		 147.48M 94.16M 93.42M 102.54M
    Cost & Expenses
    		 930.48M 727.36M 575.06M 462.83M
    Income Tax Expense
    		 18.89M -1.86M 625K 1K
    Shares Outstanding (Basic)
    		 91.43M 88.04M 79.52M 70.43M
    Shares Outstanding (Diluted)
    		 91.43M 88.04M 79.52M 70.43M
    EPS (Basic)
    		 -1.94 -5.88 -5.62 -5.48
    EPS (Diluted)
    		 -1.94 -5.88 -5.62 -5.48
    EBITDA
    		 -113.16M -477.87M -416.54M -392.38M
    EBIT
    		 -136.52M -498.32M -434.93M -406.3M
    Depreciation & Amortization
    		 23.36M 20.45M 18.39M 13.92M

    Add to Watchlist